Search

everythinglearnresearchcommunity

for

Search:↓

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

GRF is not safe for tubal occlusion.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Clascoterone safely promotes hair growth similar to minoxidil.

Blocking certain brain processes reduces mating behavior in female rats.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Switching to generic tacrolimus was safe, effective, and saved money.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Osthole inhibits the TRPV3 channel by binding to specific sites, potentially aiding drug development for skin diseases and cancers.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Nilotinib can cause keratosis pilaris, a skin condition.

New compounds may help treat heart disease by activating specific potassium channels.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.